LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

946.08 1.67

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

930.53

Max

949.45

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

1.3B

Verkäufe

3B

106B

KGV

Branchendurchschnitt

26.954

110.024

Dividendenrendite

0.33

Gewinnspanne

1.177

Angestellte

43,000

EBITDA

374M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+4.21% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.33%

2.26%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

10B

115B

Vorheriger Eröffnungskurs

944.41

Vorheriger Schlusskurs

946.08

Nachrichtenstimmung

By Acuity

39%

61%

135 / 351 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Feb. 2026, 23:44 UTC

Heiße Aktien

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

17. Feb. 2026, 23:20 UTC

Ergebnisse

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

17. Feb. 2026, 22:57 UTC

Ergebnisse

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

17. Feb. 2026, 21:59 UTC

Ergebnisse

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

17. Feb. 2026, 23:54 UTC

Market Talk

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

17. Feb. 2026, 23:54 UTC

Market Talk

Global Equities Roundup: Market Talk

17. Feb. 2026, 23:54 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. Feb. 2026, 23:45 UTC

Market Talk

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

17. Feb. 2026, 23:19 UTC

Ergebnisse

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17. Feb. 2026, 23:15 UTC

Ergebnisse

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17. Feb. 2026, 22:58 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

17. Feb. 2026, 22:58 UTC

Akquisitionen, Fusionen, Übernahmen

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

17. Feb. 2026, 22:57 UTC

Akquisitionen, Fusionen, Übernahmen

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

17. Feb. 2026, 22:50 UTC

Akquisitionen, Fusionen, Übernahmen

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

17. Feb. 2026, 22:44 UTC

Ergebnisse

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

17. Feb. 2026, 22:42 UTC

Ergebnisse

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

17. Feb. 2026, 22:36 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

17. Feb. 2026, 22:36 UTC

Ergebnisse

Santos Final Dividend 10.3 U.S. Cents/Security

17. Feb. 2026, 22:36 UTC

Ergebnisse

Santos FY Underlying Profit US$898 Million, Down 25%

17. Feb. 2026, 22:35 UTC

Ergebnisse

Santos FY Revenue US$4.94 Billion, Down 8%

17. Feb. 2026, 22:35 UTC

Ergebnisse

Correct: Santos FY Net Profit US$818 Million, Down 33%

17. Feb. 2026, 22:35 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

17. Feb. 2026, 22:34 UTC

Ergebnisse

Santos FY Net Profit US$818 Billion, Down 33%

17. Feb. 2026, 22:02 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

17. Feb. 2026, 21:50 UTC

Akquisitionen, Fusionen, Übernahmen

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

17. Feb. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

17. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. Feb. 2026, 21:49 UTC

Akquisitionen, Fusionen, Übernahmen

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

17. Feb. 2026, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

17. Feb. 2026, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

4.21% Vorteil

12-Monats-Prognose

Durchschnitt 974.09 USD  4.21%

Hoch 1,107 USD

Tief 885 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

135 / 351 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat